Does BELANTAMAB MAFODOTIN-BLMF Cause Hypercalcaemia? 5 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Hypercalcaemia have been filed in association with BELANTAMAB MAFODOTIN-BLMF. This represents 3.3% of all adverse event reports for BELANTAMAB MAFODOTIN-BLMF.
5
Reports of Hypercalcaemia with BELANTAMAB MAFODOTIN-BLMF
3.3%
of all BELANTAMAB MAFODOTIN-BLMF reports
0
Deaths
5
Hospitalizations
How Dangerous Is Hypercalcaemia From BELANTAMAB MAFODOTIN-BLMF?
Of the 5 reports, 5 (100.0%) required hospitalization, and 2 (40.0%) were considered life-threatening.
Is Hypercalcaemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BELANTAMAB MAFODOTIN-BLMF. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does BELANTAMAB MAFODOTIN-BLMF Cause?
Death (32)
Plasma cell myeloma (15)
Keratopathy (11)
Visual impairment (11)
Ocular toxicity (10)
Condition aggravated (9)
Plasma cell myeloma refractory (9)
Disease progression (7)
Dry eye (7)
Fatigue (7)
What Other Drugs Cause Hypercalcaemia?
RITUXIMAB (857)
METHOTREXATE (803)
ADALIMUMAB (663)
TOCILIZUMAB (618)
ABATACEPT (612)
ETANERCEPT (602)
DENOSUMAB (599)
ALENDRONATE (594)
INFLIXIMAB (594)
LEFLUNOMIDE (585)
Which BELANTAMAB MAFODOTIN-BLMF Alternatives Have Lower Hypercalcaemia Risk?
BELANTAMAB MAFODOTIN-BLMF vs BELATACEPT
BELANTAMAB MAFODOTIN-BLMF vs BELIMUMAB
BELANTAMAB MAFODOTIN-BLMF vs BELINOSTAT
BELANTAMAB MAFODOTIN-BLMF vs BELUMOSUDIL
BELANTAMAB MAFODOTIN-BLMF vs BELVIQ